Navigation Links
Global Genes Project Announces 'Wear That You Care™' Denim Awareness Campaign for Rare Disease Day 2011
Date:1/26/2011

DANA POINT, Calif., Jan. 26, 2011 /PRNewswire/ -- Monday, February 28, 2011, is the 4th annual Rare Disease Day — a day when people worldwide will show their support for the millions of people suffering from rare diseases and disorders.  According to statistics from the National Institutes of Health (NIH), there are approximately 7000 different rare diseases that together affect over 25 million Americans and about 250 million people globally.  It is estimated that 80% of rare diseases are caused by gene defects, and according to the Kakkis EveryLife Foundation, 95% of rare diseases do not have any FDA approved drug treatments.  Since the Orphan Drug Act was enacted 28 years ago in January 1983, only 352 new drugs have been approved by the FDA for all rare diseases combined despite incentives by the federal government.

The Global Genes Project (www.globalgenesproject.org), a leading nonprofit rare disease advocacy organization, today announced the "Wear That You Care™" Denim Campaign in support of Rare Disease Day 2011 and to call attention to the global drug development crisis facing millions of people afflicted with rare diseases.  The "Wear That You Care™" Denim campaign is simple — all across the world people can participate in supporting the rare disease movement on Rare Disease Day 2011 by wearing a Denim Jeans Ribbon™ and their favorite pair of jeans — also known as vaqueros, cowboybuksers, niuzaiku, farmernadrag and dungarees in other countries.

"Spurring development of new treatments for thousands of rare diseases is one of the most pressing health care challenges we face in the world today," said Nicole Boice, Founder, Global Genes Project.  "The goal of our effort is to create synergy among all constituents committed to finding treatments for the millions of people living wi
'/>"/>

SOURCE The Global Genes Project
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reportlinker Adds Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
2. Reportlinker Adds Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
3. Reportlinker Adds Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
4. Reportlinker Adds Magnetic Resonance Imaging (MRI) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
5. Reportlinker Adds OTC Pharmaceuticals: Global Industry Almanac
6. Intrasphere Technologies to Help Develop and Deliver Global Partner Training for the Oracle(R) Argus Safety Suite Through Oracle PartnerNetwork
7. Accuray Elevated to NASDAQ Global Select Market
8. Sinovacs Stock Exchange Listing Moves to NASDAQ Global Select Market
9. Stereotaxis Announces Global Initial Training Site at University of Chicago
10. Generex Announces Extension of Global Medical Direct Acquisition Closing Date
11. WomanCare Global Highlights the Unmet Need of 215 Million Women on Famous CBS Super Screen in Times Square
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 The Temple Health & ... to a 5,000-square-foot building at 1802 South First St. in ... designated by the City of Temple ... White and the Central Texas Veterans Health Care System, the ... space to early stage biotechnology and life science companies. ...
(Date:3/27/2015)... XRpro Sciences, Inc., a provider of ... services which features high throughput transporter and ion ... results for the year ended December 31, 2014. ... XRpro Sciences commented, "We have completed a number ... to commercial stage in large part by achieving ...
(Date:3/27/2015)... BROOKFIELD, Wis. , March 27, 2015 /PRNewswire/ ... 40,000 unit shipments of incontinence devices for women. ... terrific, but the most gratifying part is the ... receive from women whose lives have been positively ... , president of InControl. InControl recently ...
Breaking Medicine Technology:Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2
... RONKONKOMA, N.Y., March 14, 2011 NBTY, Inc. (Nasdaq: ... manufacturer and marketer of nutritional supplements in the United ... a conference call to review its fiscal first quarter ... 2011 at 10:00 AM (ET).  These results are posted ...
... health division of Eli Lilly and Company (NYSE: ... an irrevocable, unconditional offer to acquire the animal health ... Company. The two companies have notified the appropriate European ... Janssen,s animal health business is primarily European-focused, targeting disease ...
Cached Medicine Technology:NBTY to Webcast Fiscal First Quarter Conference Call 2Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health 2Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health 3
(Date:3/28/2015)... March 28, 2015 India Network ... is made available to all visitors who purchase the ... All members are encouraged to purchase the insurance program ... lack of proper coverage for pre-existing medical conditions. Parents ... or two medical conditions with serious consequences to their ...
(Date:3/28/2015)... March 28, 2015 One in three ... to research presented today at the American Orthopaedic Society ... study examined the long term success of surgery for ... examined survey data from 242 patients who underwent ACL ... P. Roe, MBBS, FRACS, from North Sydney Orthopaedic and ...
(Date:3/28/2015)... Genomic medicine experts have sequenced the ... the first time, key information for understanding and treating ... newly posted story on the Surviving Mesothelioma website. ... Columbia, the British Columbia Cancer Agency, and PhenoPath lab ... molecular alterations and mutations that can lead to ...
(Date:3/28/2015)... 2015 Healthpointe’s otolaryngologists, medical practitioners who ... disorders, are now offering a wide variety of ... is characterized by the presence of phantom sounds or ... tinnitus is a prevalent symptom that can arise due ... non-fatal, tinnitus can impede a person’s quality of life. ...
(Date:3/28/2015)... 2015 Purity Products®, a leading ... the release of their revolutionary new weight loss ... randomized, double-blind, placebo-controlled clinical studies to be effective ... size. MuffinStop™ is a combination of two traditionally ... fused together to create one of the most ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2
... ... disabled car and killed the driver. , ... New York, NY (PRWEB) February 9, 2010 -- A truck driver killed a mother of two ... His truck crashed into her disabled car on the New York State Thruway. The accident happened ...
... anxiety and depression are most likely to use a shade ... the open access journal BMC Medical Research Methodology ... Wheel, which can be used to study people,s preferred pigment ... Professor of Medicine and Gastroenterology at University Hospital South Manchester, ...
... the two drugs together, researchers say , , MONDAY, ... who take both tamoxifen and the antidepressant Paxil may ... effectiveness, Canadian researchers report. , "Paxil can deprive women ... used in combination with tamoxifen for a long time," ...
... CLEARWATER, Fla. , Feb. 8 Lincare Holdings Inc. (Nasdaq: ... year ended December 31, 2009 . , For the quarter ended ... compared with net revenues of $415.1 million for the fourth ... revenues in the fourth quarter of 2009 was comprised of 13% internal ...
... by Pier Paolo Pandolfi, at Beth Israel Deaconess Medical ... senescence (i.e., irreversible arrest of cell growth) and determined ... development and growth in mice. Previous work by ... Pten leads to a senescence response that opposes tumorigenesis. ...
... predict the progression to dementia in older adults with ... decisions) but not in those with memory dysfunction, according ... Archives of Neurology, one of the JAMA/Archives journals. ... risk factor for the development of dementia in late ...
Cached Medicine News:Health News:New York Truck Driver Watching Porn Kills Mother, Appalls Personal Injury Lawyers Such As David Perecman 2Health News:New York Truck Driver Watching Porn Kills Mother, Appalls Personal Injury Lawyers Such As David Perecman 3Health News:Depressed people feel more gray than blue 2Health News:Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer 2Health News:Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer 3Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 2Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 3Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 4Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 5Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 6Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 7Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 8Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 9Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results 10Health News:Hypertension may predict dementia in older adults with certain cognitive deficits 2
The ImmunoWELL Borrelia M Test is an enzyme immunoassay (EIA) for the qualitative and/or semiquantitative detection of Borrelia burgdorferi,IgM antibodies in serum and is used as an aid in the diag...
... Mono-G Test is a qualitative enzyme ... to Epstein-Barr virus capsid antigen (EBV-VCA), ... (CMV), and Toxoplasma. When used in ... an aid in the serodiagnosis of ...
... ImmunoWELL VCA IgM Test is an ELISA method ... Epstein-Barr Virus viral capsid antigen (VCA) in human ... in conjunction with other testing such as the ... early antigen tests and/or heterophile tests, the results ...
... Borrelia DotBlot M Tests are qualitative enzyme ... Borrelia burgdorferi antibodies (IgG or IgM, respectively) ... these tests should be supplemented with a ... can be used to support a clinical ...
Medicine Products: